Satellite Symposia

Thursday, 8 November 2018

Satellite Symposium Sanofi-Genzyme and RegeneronSAGZ Regeneron Logo 600px

Type 2 Inflammation in Severe Asthma: Clinical and Therapeutic Implications

18:15 – 19:15
Room: Zaragoza I & II
Chair: Santiago Quirce, Spain
• Welcome and Introductions. Santiago Quirce, Spain
• Defining Severe Asthma. Zuzana Diamant, The Netherlands
• Type 2 Asthma: What Is it and What Mediators Drive It? Santiago Quirce, Spain
• Interactive Session: Identifying Type 2 Asthma in Clinical Practice. G. Walter Canonica, Italy
• Closing Remarks and Panel Q&A. Santiago Quirce, Spain

Friday, 9 November 2018

Satellite Symposium Novartis

New approaches in severe allergic asthma

13:15 – 14:15
Room: Zaragoza I & II
Chair: Ignacio Dávila, Spain
• Defining the severe allergic asthma patient candidate to biologics. Santiago Quirce, Spain
• Component resolved diagnosis in severe allergic asthma. Olga Luengo, Spain

Satellite Symposium ALK

Relevant outcomes in allergic asthma

18:00 – 19:00
Room: Zaragoza I & II
Chair: Eike Wüstenberg, Germany
• Early identification of asthma deterioration for modifying or preventing severe exacerbations. A clinical trial perspective. Göran Eriksson, Sweden
• Can we influence the natural course of asthma in routine care? Eike Wüstenberg, Germany


Stay in touch

Want to get the news about all the EAACI events?
Subscribe for our events-newsletter here.